Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01031602 · ClinicalTrials.gov registry record
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
A clinical trial of Gynecologic Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 160
- Enrollment target
- 2
- Study locations
NCT01031602 is a study of Gynecologic Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 160 participants, below the 762-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01031602, a study of Gynecologic Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
Objectives: * Assess the prevalence and severity of depression and anxiety in underserved and minority women seen in the gynecologic oncology clinic at Lyndon Baines Johnson General Hospital. * Assess the prevalence and severity of sexual dysfunction in this patient population.
Conditions Studied
Interventions
- BEHAVIORAL Surveys
Study Locations (2)
Texas
- Lyndon B. Johnson (LBJ) General Hosptial - Houston
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2007-10 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01031602
The ClinicalTrials.gov registry entry for NCT01031602 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 762-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (79% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gynecologic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Surveys is the first listed.
NCT01031602 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01031602 about?
NCT01031602 is a clinical study titled "Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients". Objectives: * Assess the prevalence and severity of depression and anxiety in underserved and minority women seen in the gynecologic oncology clinic at Lyndon Baines Johnson General Hospital. * Assess the prevalence and severity of sexual dysfunction in this patient population.
What is the current status of trial NCT01031602?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2007-10. Estimated completion is 2013-05.
What conditions does trial NCT01031602 study?
This clinical trial studies the following conditions: Gynecologic Cancer.
What interventions are being tested in trial NCT01031602?
The interventions under investigation include: Surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT01031602?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01031602 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
RECRUITING
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.